Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Kang, Hyoung Jin  [Clear All Filters]
Journal Article
Kook H, Chung N-G, Kang HJin, Im HJoon. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology. Int J Hematol. 2016.
Orlikova-Boyer B, Lorant A, Gajulapalli SReddy, Cerella C, Schnekenburger M, Lee J-Y, Paik JYeon, Lee Y, Siegel D, Ross D, et al. Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation. Biomark Res. 2024;12(1):47.
Koh UNa, Lee JHyun, Kang HJin, Joo KMin, Lee JCheol, Lim S-K. Application of RapidHIT™ ID for cell authentication by fast and convenient STR profiling. Genes Genomics. 2023.
Park HJin, Hong KTaek, Han N, Kim I-W, Oh JMi, Kang HJin. Body Surface Area-Based Dosing of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Prospective Population Pharmacokinetic Study. Pharmaceutics. 2023;15(12).
Kim BKyung, Hong KTaek, Choi JYoon, Kim H, Park HJin, Kang HJin. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients. Ann Hematol. 2024.
Piao Z, Kim HJoon, Choi JYoon, Hong CRy, Lee JWon, Kang HJin, Park KDuk, Shin HYoung. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients. Int Immunopharmacol. 2015;31:132-139.
Hong KTaek, Kang YJun, Choi JYoon, Yun YJu, Chang I-M, Shin HYoung, Kang HJin, Lee W-W. Effects of Korean red ginseng on T-cell repopulation after autologous hematopoietic stem cell transplantation in childhood cancer patients. J Ginseng Res. 2024;48(1):68-76.
Lee JWon, Kang HJin, Kim S, Lee SH, Yu K-S, Kim NHee, Jang MKyoung, Kim H, Song SHoon, Park JDong, et al. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily IV busulfan fludarabine etoposide regimen in pediatric and infant ALL patients. Biol Blood Marrow Transplant. 2014.
Burke A, Vinti L, Kabickova E, Beishuizen A, Tacyildiz N, Uyttebroeck A, Kang HJin, Luisi F, Minard-Colin V, Burkhardt B, et al. Ibrutinib plus RICE/RVICI for R/R mature B-NHL in children/young adults: SPARKLE trial. Blood Adv. 2022.
Carpenter PA, Kang HJin, Yoo KHee, Zecca M, Cho B, Lucchini G, Nemecek ER, Schultz KR, Stepensky P, Chaudhury S, et al. Ibrutinib treatment of pediatric chronic graft-versus-host disease: primary results from the phase 1/2 iMAGINE study. Transplant Cell Ther. 2022.
Dimitrova D, Nademi Z, Maccari MElena, Ehl S, Uzel G, Tomoda T, Okano T, Imai K, Carpenter B, Ip W, et al. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. J Allergy Clin Immunol. 2021.
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJin, Guinipero T, Karakas Z, Bautista F, et al. The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study. Blood Adv. 2023.
Choi JYoon, Kang HJin, An HYul, Hong KTaek, Shin HYoung. Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients. Int J Hematol. 2020.
Choi S, Kim BKyung, Hong KTaek, Choi JYoon, Shin HYoung, Kang HJin. Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era. Blood Res. 2020.
Hong KTaek, Park HJin, Kim BKyung, An HYul, Choi JYoon, Kang HJin. PTCy-based Haploidentical vs Matched Unrelated Donor Peripheral Blood HSCT Using Myeloablative Targeted Busulfan-based Conditioning for Pediatric Acute Leukemia. Transplant Cell Ther. 2022.
Moon SYoung, Lim MKyoo, Hong S, Jeon Y, Han M, Song SHoon, Lim KSoo, Yu K-S, Jang I-J, Lee JWon, et al. Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry. Ann Lab Med. 2014;34(1):7-14.
Kim YJin, Kim WSun, Choi YHun, Cheon J-E, Choi JYoon, Kang HJin, Park J-E, Ryu YJin, Kim I-O. Radiologic evaluation of pulmonary injury following carmustine- and cyclophosphamide-based preparative regimen for autologous peripheral blood stem cell transplantation in children. Pediatr Radiol. 2018.
L Dupuis L, Quinones CM, Ritchie J, Carpenter PA, Bauters T, Yeh RF, Anasetti C, Boelens JJ, Hamerschlak N, Hassan M, et al. Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement". Biol Blood Marrow Transplant. 2020.
Lee KJae, Choi SJie, Yang HRan, Chang JYuong, Kang HJin, Shin HYoung, Kang GHoon, Ko JSung, Moon JSoo. Stepwise Endoscopy Based on Sigmoidoscopy in Evaluating Pediatric Graft-versus-Host Disease. Pediatr Gastroenterol Hepatol Nutr. 2016;19(1):29-37.
Kim BKyung, Hong KTaek, Kang HJin, An HYul, Choi JYoon, Hong CRy, Park KDuk, Lee DSoon, Shin HYoung. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia. J Pediatr Hematol Oncol. 2018.
Choi JYoon, Kang HJin, Hong KTaek, Hong CRy, Lee YJeong, Park JDong, Phi JHoon, Kim S-K, Wang K-C, Kim IHan, et al. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors. Int J Clin Oncol. 2019.
Lee JWon, Kang J, Choi JYoon, Hong KTaek, Kang HJin, Kwon O. Topical minoxidil and dietary supplement for the treatment of chemotherapy-induced alopecia in childhood: a retrospective cohort study. Sci Rep. 2024;14(1):4349.
Lee JAh, Choi SYul, Kang HJin, Lee JWon, Kim H, Kim JHun, Sung KWoong, Shin HYoung, Ahn HSeop, Park KDuk. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases. Br J Ophthalmol. 2014.
Choi JYoon, Kang HJin, Lee JWon, Ju HYoung, Hong CRy, Kim H, Yu YSuk, Park S-H, Cheon J-E, Park KDuk, et al. Very Late Relapse of Bilateral Retinoblastoma. J Pediatr Hematol Oncol. 2015.